Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1

被引:26
作者
Silva, Victoria C. [1 ]
Cassimeris, Lynne [1 ]
机构
[1] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA
基金
美国国家卫生研究院;
关键词
SMALL-MOLECULE INHIBITOR; POLO-LIKE KINASE-1; DOWN-REGULATION; ONCOPROTEIN; 18; CANCER-CELLS; CENTROSOMAL PROTEIN; PHOSPHORYLATION; CYCLE; EXPRESSION; TARGET;
D O I
10.1091/mbc.E13-02-0108
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Depletion of stathmin, a microtubule (MT) destabilizer, delays mitotic entry by similar to 4 h in HeLa cells. Stathmin depletion reduced the activity of CDC25 and its upstream activators, Aurora A and Plk1. Chemical inhibition of both Aurora A and Plk1 was sufficient to delay mitotic entry by 4 h, while inhibiting either kinase alone did not cause a delay. Aurora A and Plk1 are likely regulated downstream of stathmin, because the combination of stathmin knockdown and inhibition of Aurora A and Plk1 was not additive and again delayed mitotic entry by 4 h. Aurora A localization to the centrosome required MTs, while stathmin depletion spread its localization beyond that of.-tubulin, indicating an MT-dependent regulation of Aurora A activation. Plk1 was inhibited by excess stathmin, detected in in vitro assays and cells overexpressing stathmin-cyan fluorescent protein. Recruitment of Plk1 to the centrosome was delayed in stathmin-depleted cells, independent of MTs. It has been shown that depolymerizing MTs with nocodazole abrogates the stathmin-depletion induced cell cycle delay; in this study, depolymerization with nocodazole restored Plk1 activity to near normal levels, demonstrating that MTs also contribute to Plk1 activation. These data demonstrate that stathmin regulates mitotic entry, partially via MTs, to control localization and activation of both Aurora A and Plk1.
引用
收藏
页码:3819 / 3831
页数:13
相关论文
共 79 条
[11]   Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin [J].
Chen, Yangchao ;
Lin, Marie C. ;
Yao, Hong ;
Wang, Hua ;
Zhang, Ai-Qun ;
Yu, Jun ;
Hui, Chee-kin ;
Lau, George K. ;
He, Ming-liang ;
Sung, Joseph ;
Kung, Hsiang-fu .
HEPATOLOGY, 2007, 46 (01) :200-208
[12]   Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition [J].
Dutertre, S ;
Cazales, M ;
Quaranta, M ;
Froment, C ;
Trabut, V ;
Dozier, C ;
Mirey, G ;
Bouché, JP ;
Theis-Febvre, N ;
Schmitt, E ;
Monsarrat, B ;
Prigent, C ;
Ducommun, B .
JOURNAL OF CELL SCIENCE, 2004, 117 (12) :2523-2531
[13]   Significance of microtubule catastrophes at focal adhesion sites [J].
Efimov, A. ;
Kaverina, I. .
CELL ADHESION & MIGRATION, 2009, 3 (03) :285-287
[14]   A novel mechanism for activation of the protein kinase aurora A [J].
Eyers, PA ;
Erikson, E ;
Chen, LG ;
Maller, JL .
CURRENT BIOLOGY, 2003, 13 (08) :691-697
[15]   Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase [J].
Ezratty, EJ ;
Partridge, MA ;
Gundersen, GG .
NATURE CELL BIOLOGY, 2005, 7 (06) :581-U15
[16]   Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3 [J].
Fu, Siqing ;
Li, Yanfang ;
Huang, Jie ;
Liu, Tao ;
Hong, Zhen ;
Chen, Aiping ;
Bast, Robert C. ;
Kavanagh, John J. ;
Gershenson, David M. ;
Sood, Anil K. ;
Hu, Wei .
CANCER BIOLOGY & THERAPY, 2012, 13 (11) :1034-1041
[17]   Aurora B is required for mitotic chromatin-induced phosphorylation of Op18/Stathmin [J].
Gadea, BB ;
Ruderman, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (12) :4493-4498
[18]   Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536 [J].
Gleixner, Karoline V. ;
Ferenc, Veronika ;
Peter, Barbara ;
Gruze, Alexander ;
Meyer, Renata A. ;
Hadzijusufovic, Emir ;
Cerny-Reiterer, Sabine ;
Mayerhofer, Matthias ;
Pickl, Winfried F. ;
Sillaber, Christian ;
Valent, Peter .
CANCER RESEARCH, 2010, 70 (04) :1513-1523
[19]   Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells [J].
Grinshtein, Natalie ;
Datti, Alessandro ;
Fujitani, Mayumi ;
Uehling, David ;
Prakesch, Michael ;
Isaac, Methvin ;
Irwin, Meredith S. ;
Wrana, Jeffrey L. ;
Al-awar, Rima ;
Kaplan, David R. .
CANCER RESEARCH, 2011, 71 (04) :1385-1395
[20]   Quantitative Phospho-proteomics to Investigate the Polo-like Kinase 1-Dependent Phospho-proteome [J].
Grosstessner-Hain, Karin ;
Hegemann, Bjoern ;
Novatchkova, Maria ;
Rameseder, Jonathan ;
Joughin, Brian A. ;
Hudecz, Otto ;
Roitinger, Elisabeth ;
Pichler, Peter ;
Kraut, Norbert ;
Yaffe, Michael B. ;
Peters, Jan-Michael ;
Mechtler, Karl .
MOLECULAR & CELLULAR PROTEOMICS, 2011, 10 (11)